Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada.


Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 12 01 2019
revised: 16 02 2019
accepted: 13 03 2019
pubmed: 2 4 2019
medline: 25 7 2019
entrez: 2 4 2019
Statut: ppublish

Résumé

Perfluoroalkyl substances (PFASs) are known to be toxic, bioaccumulative, and persistent. However, exposure routes and toxic effects to humans are still widely unknown. Our objectives were to evaluate potential correlations between concentrations of PFASs in maternal plasma and infant cord blood with home characteristics and developmental effects, including wheezing. The concentrations of 17 PFASs were measured in plasma from prenatal women (n = 414), postnatal women (n = 247), and cord blood (n = 50) from a subset of participants in a population-based birth cohort in Winnipeg, Manitoba, Canada, using online solid phase extraction (SPE) with liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Multiple linear regression and principal component analysis (PCA) were used to evaluate possible associations with PFAS concentrations. Surveys were used to collect information regarding maternal characteristics (e.g. age, parity, duration of breastfeeding), infant characteristics (e.g. birth weight, birth length, head circumference, gestational age, and incidence of recurrent wheezing), and home characteristics (e.g. home age,carpet coverage in the most used room, presence of new furniture, or recent home renovations). PFASs in plasma were associated with maternal characteristics but not home characteristics or early childhood wheezing. PFASs were not associated with developmental effects, with the exception that perfluoroundecanoic acid (PFUA) was negatively associated with birth weight. Further studies investigating the potential influences of PFUA on birth weight are warranted.

Identifiants

pubmed: 30933773
pii: S0269-7491(19)30061-2
doi: 10.1016/j.envpol.2019.03.054
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Fatty Acids 0
Fluorocarbons 0
perfluoroundecanoic acid 0

Types de publication

Journal Article

Langues

eng

Pagination

758-766

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Clare E Workman (CE)

Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: clare.elizabeth.mc@gmail.com.

Allan B Becker (AB)

Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.

Meghan B Azad (MB)

Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.

Theo J Moraes (TJ)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Piush J Mandhane (PJ)

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Stuart E Turvey (SE)

Department of Pediatrics, Child & Family Research Institute, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Padmaja Subbarao (P)

Department of Pediatrics & Physiology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Jeffrey R Brook (JR)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Malcolm R Sears (MR)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Charles S Wong (CS)

Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Environmental Studies and Sciences, The University of Winnipeg, Richardson College for the Environment, Winnipeg, Manitoba, Canada; Department of Chemistry, The University of Winnipeg, Richardson College for the Environment, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH